Helping You Build Wealth With Honest Research
Since 1996. Read On...

MEMBER'S LOGIN

MEMBER'S LOGINX

     
Invalid Username / Password
   
     
   
     
 
Invalid Captcha
   
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

Revealed
India's Third Giant Leap

This Could be One of the Biggest Opportunities for Investors




Important: We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
By submitting your email address, you also sign up for Profit Hunter, a daily newsletter from Equitymaster
covering exciting investing ideas and opportunities in India.

AD

Realty stocks lead Indian markets
Wed, 7 Sep 09:30 am

Asian stock markets have opened the day on a firm note. Stock markets in South Korea (up 2.7%), Japan (up 1.7%), Hong Kong (up 1.2%), China (up 1.1%) and Indonesia (up 1%) are trading in the green. Indian stock market too have opened the day on a firm note. Stocks in the Realty and Banking space are leading the gains.

The BSE-Sensex is trading up by 150 points (0.9%) and the NSE-Nifty is up by around 35 points (0.7%). BSE Midcap and BSE Small cap stocks are trading in the green, with the BSE Mid Cap and BSE Small Cap indices are up by 0.8% and 0.6% respectively. The rupee is trading at 45.89 to the US dollar.

Power stocks have opened the day on a firm note with Jaiprakash Power and National Thermal Power Corporation (NTPC) in the green. Public sector unit, NTPC, has decided to venture in the international market. This is its first overseas venture and will operate a US$ 700 m coal-based power plant in Sri Lanka. It has entered into a JV with Ceylon Electricity Board (CEB) and will be a part of establishing a 500 MW plant (2x250 MW) in the eastern part of Sri Lanka. Both the companies will have equity in the JV and the JV will be incorporated in Sri Lanka. Once the JV will be incorporated, both the companies will go ahead with the remaining documentation and agreements including the power purchase agreement with CEB, board of investment agreement with the Board of Investment and implementation agreement with the Government of Sri Lanka. The agreements are ready and the project is expected to achieve a financial closure in this financial year.

Pharma stocks have opened the day on a firm note with Ranbaxy Laboratories, Aurobindo Pharma and Cadila Healthcare leading the gains. Cipla, the second largest Indian pharma company, has shut down two of its four marketing divisions. The company has said that the rationalisation move was taken to improve distribution and thus, productivity. The two divisions, Protec and Omnicare, sold generic products and generated sales worth Rs 5 bn. The company has also stated that it will not be slashing any of its products. Cipla has a strong sales force comprising 7,000 sales representatives. By far, this is the largest in the industry. The company sells over 2,000 products in 65 therapeutic areas.

For information on how to pick stocks that have the potential to deliver big returns, download our special report now!

View all commentaries | Archives

Read the latest Market Commentary


Equitymaster requests your view! Post a comment on "Realty stocks lead Indian markets". Click here!

  
ABOUT EQUITYMASTER

Since 1996, Equitymaster has been the source for honest and credible opinions on investing in India. With solid research and in-depth analysis Equitymaster is dedicated towards making its readers- smarter, more confident and richer every day. Here's why hundreds of thousands of readers spread across more than 70 countries Trust Equitymaster.

PREMIUM PRODUCTS
QUICK LINKS
POPULAR TOPICS
TRENDING TOPICS
FREE NEWSLETTERS
EQUITYMASTER SUPPORTS
  • HelpYourNGO
  • You Tube
  • Linkedin
  • Twitter
  • Telegram
  • Google Play

Copyright © Equitymaster Research Private Limited (formerly Equitymaster Agora Research Private Limited).

Whitelist | Refer | Terms | Privacy | Contact | About | Sitemap

Phone +91-9136015013

Equitymaster Research Private Limited (formerly Equitymaster Agora Research Private Limited) (Research Analyst)
SEBI (Research Analysts) Regulations 2014, Registration No. INH000000537.

103, Regent Chambers, Above Status Restaurant, Nariman Point, Mumbai - 400 021. India.
Telephone: +91-22-61434055. Email: info@equitymaster.com. Website: www.equitymaster.com.
CIN:U74999MH2007PTC175407

Name of the Compliance & Grievance Officer: Ms Sonal Ramachandran
Telephone: +91-22-61434003 | Email: compliance@equitymaster.com

LEGAL DISCLAIMER:
Investment in securities market are subject to market risks. Read all the related documents carefully before investing.
Registration granted by SEBI and certification from NISM in no way guarantee performance of the intermediary or provide any assurance of returns to investors.

All rights reserved. Any act of copying, reproducing or distributing this newsletter whether wholly or in part, for any purpose without the permission of Equitymaster is strictly prohibited and shall be deemed to be copyright infringement.

Equitymaster Research Private Limited (formerly Equitymaster Agora Research Private Limited) (Research Analyst) bearing Registration No. INH000000537 (hereinafter referred as 'Equitymaster') is an independent equity research Company. Equitymaster is not an Investment Adviser. Information herein should be regarded as a resource only and should be used at one's own risk. This is not an offer to sell or solicitation to buy any securities and Equitymaster will not be liable for any losses incurred or investment(s) made or decisions taken/or not taken based on the information provided herein. Information contained herein does not constitute investment advice or a personal recommendation or take into account the particular investment objectives, financial situations, or needs of individual subscribers. Before acting on any recommendation, subscribers should consider whether it is suitable for their particular circumstances and, if necessary, seek an independent professional advice. This is not directed for access or use by anyone in a country, especially, USA, Canada or the European Union countries, where such use or access is unlawful or which may subject Equitymaster or its affiliates to any registration or licensing requirement. All content and information is provided on an 'As Is' basis by Equitymaster. Information herein is believed to be reliable but Equitymaster does not warrant its completeness or accuracy and expressly disclaims all warranties and conditions of any kind, whether express or implied. Equitymaster may hold shares in the company/ies discussed herein. As a condition to accessing Equitymaster content and website, you agree to our Terms and Conditions of Use, available here. The performance data quoted represents past performance and does not guarantee future results.